My father-in-law, Abraham Colton,
passed away at age 77 from Lymphoma cancer
We are developing new tools to analyze cancer evolution and are applying our findings in a clinical setting.
Recent technological developments in generating biological data, such as next-generation DNA/RNA sequencing, has led to an exponential growth of biological data. This is particularly true of cancer data, as DNA sequencing is a routine procedure at many medical centers. The main bottleneck for research is therefore not in data generation but rather in interpreting this wealth of data. In our lab, we develop new algorithms and computational tools for analyzing cancer data, and apply them to the abundance of newly available data, with the goal of generating new biological insights and medical diagnostic tools.
While our interest spans all aspects of cancer bioinformatics, our current main focus is on the genomics of tumors that develop due to a deficiency in one of the DNA repair pathways.
As examples, two of the lab's current projects include:
- 1. Cancer early detection using cell-free DNA: We are developing computational methods to analyze cell-free DNA in the blood in order to be able to detect traces of cancerous DNA from the blood. This may be useful both for early detection of cancer and for monitoring the relapse of previous tumors.
- 2. Preventative vaccine for colon cancer for Lynch Syndrome patients: A familial syndrome with a predisposition to colon cancer called Lynch Syndrome is characterized by highly frequent mutations. We are analyzing samples from an early cancerous lesion, and predicting which of these mutations are likely to lead to an immune response, and therefore can be used for a preventive vaccine against tumor development.
The lab is multidisciplinary and candidates backgrounds can range from medical
studies or basic biology to computer science and applied mathematics or the like.
Yosef Maruvka - Principal Investigator
To read about my research see Research section
Research associate/Lab manager
Shai Naparstek - Research associate/Lab manager
Hi!, I'm the new lab manager
Hagay Ladany - PhD student
My research is based on the assumption that random mutations arising during DNA replication in normal, non-cancerous stem cells may contribute to cancer development. Therefore, estimating the mutation-rate in which an individual accumulates mutations can help to predict cancer development for each individual, as well as predict characteristics of the emergence of drug resistance for each individual and each drug.
Jorge Cano Nistal
Jorge Cano Nistal -PhD student
Born in León, Spain. B.Sc. in Biology, M.Sc. in Innovation in Biomedicine & Health Science (University of León) and passionate about Mathematics, Physics and Scientific Communication as well. My passion for science started at an early age and grew over the years.Now, as a PhD Student at Maruvka Lab, I am willing to help people by researching in the amazing field of Cancer Bioinformatics. As one of the greatest scientists of all times said once: “If I have seen further, it is by standing upon the shoulder of giants”.
Daniel Gurevich - M.sc. student
- B.Sc. in Biotechnology and Food Engineering from the Technion- Israel Institute of Technology (2020).
- Joined the team on March 2020.
Characterization of cancer by using ensemble learning algorithms.
Gaia Frant (MSc student)
I have received my B.Sc in Biotechnology and Food Engineering from the Technion.
My research is currently focused on better characterizing the MMR system through the analysis of different cancer types.
Guy Shani - MSc student
I have just received my B.Sc in material engineering and physics.
I am developing computational tools that can detect cancerous DNA in the cell free DNA. These tools can be used for early detection.
Avraham Kahan (Research assistant)
I am interested in the development of efficient algorithms and heuristics to model and analyze biological systems.
Currently, my research is focused on developing computational tools to deduce molecular characteristics of tumors from imaging and sequencing data
Sahar (Haozhen Hong)
I am Haozhen Hong from China.
I got the B.Sc degree from GTIIT – Guangdong Technion in China and then joined the lab in October 2021.
Currently, my general research direction is to analyse AML cancer by nanopore sequencing.
I have a B.Sc in Biotechnology from Tel-Hai college, summa cum laude.
I've also taken several courses related to Computer Science, and have been a bioinformatician at the Faculty of Medicine, Technion for the past year at the Preger Lab.
Currently, I'm an M.Sc student, and my project is going to be about diagnosing cancer from cell-free DNA (cfDNA) of patients, within low-coverage whole genome sequencing.
Ofek (Yu LIN)
Ofek (MSc student)
I am Yu LIN, also known as Ofek, from China.
I graduated with a BSc degree in Biotechnology and Food Engineering from Guangdong Technion in 2021.
I joined Maruvka Lab as a Master's student in summer 2021.
I will take part in the laboratory and computational side of oncology research.
I am currently working as a Research Assistant.
Betzalel Evans (International intern)
I am a 2nd year Chemical Engineering Student at the Cooper Union in New York City.
I will be working in the lab under the title of "International summer intern".
Dr. Amir B. Cohanim
Dr. Amir B. Cohanim
I am a computational biologist. Chromatin structure and Epigenetics were my main fields of research during my doctoral- and postdoctoral- studies, at the Technion, and ENS - Paris. Currently I am working in Dr. Yosef Maruvka Lab on Microsatellite Instability (MSI).
The aim of my research is to analyze the mutational pattern of 126 mammalian species, study the mutational events that shaped the evolution of those species, and compare the results with the data we have on humans.
I am a fourth-year B.Sc. student at the Faculty of Biotechnology and Food Engineering.
Currently, I am working on my B.Sc research project, on the topic of somatic mutations in pediatric acute myeloid leukemia.
We are looking for an experimentalist post-doc with a background in cell-biology and genomics. Previous experience in cancer research is an advantage.
We are also looking for a computational PhD student for a tool development project. Relevant background, computer science, mathematics, physics or similar.
While we have enough personnel with biological background, we may have some opening for excellent PhD student.
Please contact us at: [email protected]
Our lab collaborates with a startup company Foresee Genomics in developing inexpensive and easy-to-use sequencing protocols based on Nanopore sequencing technology. Foresee Genomics develops a combined system of molecular biology and bioinformatics. An enabling technology with the purpose to increase the accuracy of the currently error-prone nanopore-based 4th generation DNA sequencing technology, transforming it into a technology that would be suitable for sensitive diagnostics. The nanopore sequencing platform is significantly inexpensive in comparison to all other NGS platforms. The combined system of Foresee Genomic and the nanopore sequencer is an end-to-end solution for genomic diagnostics which is accurate and affordable. We give labs the capability to do comprehensive molecular testing at an unprecedented price.
Due to the loss of two dear and beloved people, my research shifted from a theoretical focus to a more applied cancer focus.
My father-in-law, Abraham Colton,
My cousin, Dov (Irad) Eisenbach,
passed away at age 33 from tongue cancer.
Applications and CVs can be sent to our email.
For any questions or concerns please contact us by email or phone.
Technion – Israel Institute of Technology Haifa, 3200, Emerson Building 3-4
This accessibility statement applies to MaruvkaLab.com
This website build and run by Yosi Maruvka's lab staff.
- This website complies with the requirements of the Equal Rights for Persons with Disabilities (Service Accessibility Adjustments), 2013.
The accessibility adjustments were made according to the recommendations of the Israeli standard (TI 5568) for content accessibility on the Internet at level AA and the international WCAG2.0 document.
- The website accessibility was tested for the highest compatibility for Google Chrome and Microsoft Edge browsers.
- The website provides support for keyboard operation using the standard website navigation keys. See the website operation section for details.
- The website is optimized for display in common browsers and for use on the cell phone.
- website operation: Keyboard shortcuts to navigate the site using the keyboard: use the Tab button. Each click will take you to the next object. Clicking Shift + Tab will take you back to the previous object. Up/Down arrow keys will scroll the website without selecting any object. Enter/Escape keys will submit/exit the selected object.
- Change site contrast using the bottom right dedicated contrast button.
- Enlarge font size using the bottom right dedicated Aa button.
- Listen to most of the website using a screen readers - Tested with Windows Narrator and NVDA on Google Chrome and Microsoft Edge browsers.
- There is a limit to how far you can enlarge the text size using browser's zoom.
- Some parts of this website may not fully accessible.
We're always looking to improve the accessibility of this website. If you find any problems not listed on this page or think we're not meeting accessibility requirements, contact us.